Stockreport

IBN Coverage: TransCode Therapeutics (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138 [Yahoo! Finance]

TransCode Therapeutics, Inc.  (RNAZ) 
PDF LOS ANGELES, CA - May 1, 2025 ( NEWMEDIAWIRE TransCode Therapeutics (NASDAQ: RNAZ) reported continued progress in its Phase 1a trial of TTX-MC138, an RNA-based therapeu [Read more]